Mae ystod o gamau yn cael eu cymryd i liniaru effaith y tarfu ar gyflenwadau penodol gan gynnwys rhoi cyngor clinigol i bresgripsiynwyr ar driniaethau amgen; cyhoeddi Protocolau Prinder Difrifol i alluogi i fferyllfeydd roi dewisiadau amgen sy'n briodol yn glinigol pan na allant gael meddyginiaeth sydd wedi'i ragnodi, a chyfyngu ar allforio meddyginiaethau sy'n brin.
A range of actions are being taken to mitigate the impact of these specific supply disruptions including providing prescribers with clinical advice on alternative treatment approaches; issuing Serious Shortage Protocols to allow pharmacies to substitute clinically appropriate alternatives when they are unable to obtain a prescribed medicine, and restricting the export of medicines in short supply.